Crossject SA (74C)
FSX
Closed
Oct 9, 2026
Day's Range
1.2952 wk Range
1.28Overview - 74C - Crossject SA
Key Statistics
Valuation
Enterprise Value
89.56M
P/E (Trailing)
‪-7.01‬
Price / Sales (TTM)
‪32.10‬
EV / EBITDA
‪-8.40‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-629.28%‬
Return on Assets
‪-23.40%‬
Return on Equity
‪212.74%‬
Ownership
Shares Outstanding
52.18M
Float
51.16M
Held by Insiders
‪19.74%‬
Held by Institutions
‪0.40%‬
Price stats
Beta
‪0.49‬
50-Day Avg
‪1.41‬
200-Day Avg
‪1.78‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 74C - Crossject SA
Peers - 74C - Crossject SA
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on FSX.
- 74CFSXCrossject SA80.28MMarket Cap-39.64%52-week change-7.01P/E (Trailing)‪0.00%‬Profit Margin
- IUI1FSXIntuitive Surgical Inc.128.27BMarket Cap-7.31%52-week change48.16P/E (Trailing)‪28.44%‬Profit Margin
- ESLFSXEssilorLuxottica66.69BMarket Cap-88.14%52-week change27.85P/E (Trailing)‪8.51%‬Profit Margin
- ESLCFSXEssilorLuxottica S.A. Unsponsored ADR66.51BMarket Cap-92.96%52-week change27.15P/E (Trailing)‪8.51%‬Profit Margin
- HYBFSXHOYA Corporation47.91BMarket Cap+12.22%52-week change31.63P/E (Trailing)‪27.17%‬Profit Margin
- HYB0FSXHoya Corporation Sponsored ADR47.03BMarket Cap+11.51%52-week change33.10P/E (Trailing)‪27.17%‬Profit Margin
- BOXFSXBecton, Dickinson and Company42.69BMarket Cap-5.14%52-week change30.74P/E (Trailing)‪4.19%‬Profit Margin
Profile Summary - 74C - Crossject SA
About
Crossject SA is a France-based specialty pharmaceutical company that develops needle-free drug delivery systems for emergency medical use. Its core platform, ZENEO, is a prefilled, single-use auto-injector designed to help patients and untrained caregivers administer medication quickly and simply. The company focuses…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
